DR. ENRICO PAUL VELTRI, M.D.
Osteopathic Medicine at Toftrees Ct, Princeton, NJ
License number
New Jersey D0028040
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
6 Toftrees Ct, Princeton, NJ 08540
Phone
(609) 219-9078
Personal information
See more information about ENRICO PAUL VELTRI at radaris.comName
Address
Phone
6 Toftrees Ct, Princeton, NJ 08540
6 Toftrees, Lawrence Township, NJ 08540
119 Fielder Ave, Seaside Heights, NJ 08751
6 Toftrees Ct, Princeton, NJ 08540
410 6Th Ave, Paterson, NJ 07514
Professional information
Dr. Enrico P Veltri, Princeton NJ - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
6 Toftrees Ct, Princeton 08540
(609) 219-9078 (Phone)
(609) 219-9078 (Phone)
Certifications:
Cardiovascular Disease, 1985, Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 1979
Mount Sinai Hospital
The Johns Hopkins Hospital
University of Medicine And Dentistry of New Jersey / Newark
Graduated: 1979
Mount Sinai Hospital
The Johns Hopkins Hospital
Thrombin Receptor Antagonists As Prophylaxis To Complications From Cardiopulmonary Surgery
US Patent:
2007020, Aug 30, 2007
Filed:
Dec 20, 2006
Appl. No.:
11/613450
Inventors:
Enrico Veltri - Princeton NJ, US
John Strony - Lebanon NJ, US
Gail Berman - Westfield NJ, US
John Strony - Lebanon NJ, US
Gail Berman - Westfield NJ, US
International Classification:
A01N 25/08
US Classification:
424409000
Abstract:
Disclosed herein are methods of preventing, inhibiting, or ameliorating complications associated with cardiopulmonary bypass surgery by the use of a thrombin receptor antagonist compound. Among the thrombin receptor antagonist compounds useful in these methods are those of Formulas I and II, described herein. Examples of such thrombin receptor antagonists include:
Methods Of Use Of Thrombin Receptor Antagonists
US Patent:
2004019, Sep 30, 2004
Filed:
Nov 10, 2003
Appl. No.:
10/705282
Inventors:
Samuel Chackalamannil - Califon NJ, US
Yan Xia - Edison NJ, US
Enrico Veltri - Princeton NJ, US
Mariappan Chelliah - Edison NJ, US
Wenxue Wu - Princeton Junction NJ, US
Michael Graziano - Scotch Plains NJ, US
Teddy Kosoglou - Jamison PA, US
Madhu Chintala - Colts Neck NJ, US
Yan Xia - Edison NJ, US
Enrico Veltri - Princeton NJ, US
Mariappan Chelliah - Edison NJ, US
Wenxue Wu - Princeton Junction NJ, US
Michael Graziano - Scotch Plains NJ, US
Teddy Kosoglou - Jamison PA, US
Madhu Chintala - Colts Neck NJ, US
International Classification:
A61K031/404, A61K031/365
US Classification:
514/411000, 514/418000, 514/470000
Abstract:
A method of treating a therapeutic condition comprising administering to a mammal in need of such treatment an effective amount of at least one compound of the formulas:
or a pharmaceutically acceptable isomer, salt, solvate or co-crystal form thereof, wherein the substituents are as defined in the specification, wherein said therapeutic condition is a cardiovascular or circulatory disease or condition, an inflammatory disease or condition, a respiratory tract or disease or condition, cancer, acute renal failure, astrogliosis, a fibrotic disorder of the liver, kidney, lung or intestinal tract, Alzheimer's disease, diabetes, diabetic neuropathy, rheumatoid arthritis, neurodegenerative disease, neurotoxic disease, systemic lupus erythematosus, multiple sclerosis, osteoporosis, glaucoma, macular degeneration, psoriasis, radiation fibrosis, endothelial dysfunction, a wound or a spinal cord injury, or a symptom or result thereof. Combination therapy with other therapeutically effective agents is also disclosed.
Methods And Therapeutic Combinations For The Treatment Of Obesity Using Sterol Absorption Inhibitors
US Patent:
2003011, Jun 26, 2003
Filed:
Sep 19, 2002
Appl. No.:
10/247397
Inventors:
Harry Davis - Berkeley Heights NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Rudyard Ress - Flemington NJ, US
John Strony - Lebanon NJ, US
Enrico Veltri - Princeton NJ, US
Assignee:
Schering Corporation
International Classification:
B24B001/00
US Classification:
451/059000
Abstract:
The present invention provides methods for the treatment of obesity using sterol or 5-stanol absorption inhibitors and compositions and therapeutic combinations including sterol or 5-stanol absorption inhibitors and at least one obesity control medication.
Tra Combination Therapies
US Patent:
2007023, Oct 11, 2007
Filed:
Apr 5, 2007
Appl. No.:
11/696898
Inventors:
Enrico Veltri - Princeton NJ, US
William Greenlee - Teaneck NJ, US
William Greenlee - Teaneck NJ, US
International Classification:
A61K 31/704, A61K 31/554, A61K 31/4433, A61K 31/455, A61K 31/401, A61K 31/366, A61K 31/22, A61K 31/138
US Classification:
514026000, 514337000, 514355000, 514252170, 514305000, 514457000, 514262100, 514651000, 514423000, 514460000, 514548000, 514211070
Abstract:
Disclosed herein are pharmaceutical combinations comprising at least one thrombin receptor antagonist and at least one cardiovascular agent. Examples of such a thrombin receptor antagonist include:
Examples of cardiovascular agents suitable for co-formulation or co-administration with the thrombin receptor antagonist include an endothelin antagonist selected from the group consisting of tezosentan, bosentan, and sitaxsentan.
Methods And Therapeutic Combinations For The Treatment Of Autoimmune Disorders
US Patent:
2004009, May 13, 2004
Filed:
Nov 4, 2003
Appl. No.:
10/700909
Inventors:
John Erbey - Flemington NJ, US
Jay Fine - Bloomfield NJ, US
Enrico Veltri - Princeton NJ, US
Jay Fine - Bloomfield NJ, US
Enrico Veltri - Princeton NJ, US
Assignee:
Schering Corporation
International Classification:
A61K031/397
US Classification:
514/210020
Abstract:
The present invention provides methods for treating or preventing an autoimmune disorder and associated conditions by administering at least one sterol absorption inhibitor and compositions, therapeutic combinations and methods including: (a) at least one sterol absorption inhibitor; and (b) at least one autoimmune disorder treatment which can be useful for preventing or treating an autoimmune disorder and associated conditions.
Methods And Therapeutic Combinations For The Treatment Of Diabetes Using Sterol Absorption Inhibitors
US Patent:
7071181, Jul 4, 2006
Filed:
Sep 19, 2002
Appl. No.:
10/247099
Inventors:
Harry R. Davis - Berkeley Heights NJ, US
Teddy Kosoglou - Jamison PA, US
Gilles J. Picard - Braine L'Alleud, BE
Rudyard J. Ress - Flemington NJ, US
John T. Strony - Lebanon NJ, US
Enrico P. Veltri - Princeton NJ, US
Teddy Kosoglou - Jamison PA, US
Gilles J. Picard - Braine L'Alleud, BE
Rudyard J. Ress - Flemington NJ, US
John T. Strony - Lebanon NJ, US
Enrico P. Veltri - Princeton NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31/397, A61K 31/7052
US Classification:
51421002, 514 23, 514 25, 536 174
Abstract:
The present invention provides methods of treating diabetes and associated conditions by administering a composition including at least one sterol or 5α-stanol absorption inhibitor or compositions or therapeutic combinations including: (a) at least one antidiabetic medication; and (b) at least one sterol or 5α-stanol absorption inhibitor.
Combination Of An H3 Antagonist/Inverse Agonist And An Appetite Suppressant
US Patent:
2007014, Jun 21, 2007
Filed:
Dec 18, 2006
Appl. No.:
11/640729
Inventors:
Margaret van Heek - Scotch Plains NJ, US
Joyce Hwa - Westfield NJ, US
Michael Graziano - Scotch Plains NJ, US
Jean Lachowicz - Berkeley Heights NJ, US
Timothy Kowalski - Plainsboro NJ, US
Enrico Veltri - Princeton NJ, US
Kevin McCormick - Basking Ridge NJ, US
Michael Berlin - Flemington NJ, US
Robert Aslanian - Rockaway NJ, US
Joyce Hwa - Westfield NJ, US
Michael Graziano - Scotch Plains NJ, US
Jean Lachowicz - Berkeley Heights NJ, US
Timothy Kowalski - Plainsboro NJ, US
Enrico Veltri - Princeton NJ, US
Kevin McCormick - Basking Ridge NJ, US
Michael Berlin - Flemington NJ, US
Robert Aslanian - Rockaway NJ, US
International Classification:
A61K 31/541, A61K 31/517, A61K 31/4745, A61K 31/4192, A61K 31/428, A61K 31/496, A61K 31/5377, A61K 31/423, A61K 31/4184, A61K 31/4178
US Classification:
514227500, 514373000, 514397000, 514394000, 514303000, 514266200, 514367000, 514359000, 514375000, 514227800, 514235500, 514254050
Abstract:
The present invention relates to pharmaceutical compositions comprising therapeutic combinations comprising: one or more Hantagonists/inverse agonists; one or more appetite suppressants selected from the group consisting of CBantagonists/inverse agonists, sibutramine, phentermine and topiramate; and optionally one or more HMG-CoA reductase inhibitors. The invention also relates to medicaments and kits comprising the pharmaceutical compositions of the present invention, and methods of treating obesity, obesity related disorders and diabetes using the pharmaceutical compositions of the present invention.
Pharmacokinetically-Based Dosing Regiments Of A Thrombin Receptor Antagonist
US Patent:
2012002, Feb 2, 2012
Filed:
Nov 16, 2009
Appl. No.:
13/129725
Inventors:
Larisa Reyderman - Watchung NJ, US
Teddy Kosoglou - Jamison PA, US
Enrico P. Veltri - Princeton NJ, US
Teddy Kosoglou - Jamison PA, US
Enrico P. Veltri - Princeton NJ, US
International Classification:
A61K 31/443, A61K 31/5377, A61P 9/00, A61K 31/444
US Classification:
5142352, 514333, 514337
Abstract:
Dosing regimens based on the pharmacokinetic characteristics of a thrombin receptor antagonist are disclosed. In some embodiments, the dosing regimens result in mean plasma concentrations. Also disclosed are methods of treating acute coronary syndrome and peripheral arterial disease, and of effecting secondary prevention, by orally administering thrombin receptor antagonists according to such dosing regimens.
Thrombin Receptor Antagonists
US Patent:
2007027, Nov 22, 2007
Filed:
Jul 6, 2007
Appl. No.:
11/774358
Inventors:
Samuel Chackalamannil - Califon NJ, US
Martin Clasby - Plainsboro NJ, US
William Greenlee - Teaneck NJ, US
Yuguang Wang - North Brunswick NJ, US
Yan Xia - Edison NJ, US
Enrico Veltri - Princeton NJ, US
Mariappan Chelliah - Edison NJ, US
Martin Clasby - Plainsboro NJ, US
William Greenlee - Teaneck NJ, US
Yuguang Wang - North Brunswick NJ, US
Yan Xia - Edison NJ, US
Enrico Veltri - Princeton NJ, US
Mariappan Chelliah - Edison NJ, US
International Classification:
A61K 31/4427, A61K 31/506, A61P 29/00, A61P 35/00, A61P 9/00, A61P 9/02, A61P 9/06, A61P 9/10, A61P 9/12, C07D 221/00, C07D 239/26
US Classification:
514256000, 514314000, 514333000, 514337000, 544333000, 546180000, 546256000, 546270400, 546284100
Abstract:
Heterocyclic-substituted tricyclics of the formula
or a pharmaceutically acceptable salt thereof, wherein: